Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Pain-measurement tools in sickle cell disease: where are we now?

Darbari DS, Brandow AM.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):534-541. doi: 10.1182/asheducation-2017.1.534. Review.

2.

Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.

Kato-Lin YC, Krishnamurti L, Padman R, Seltman HJ.

Int J Med Inform. 2014 Nov;83(11):814-24. doi: 10.1016/j.ijmedinf.2014.08.003. Epub 2014 Aug 17.

PMID:
25179666
3.

Sickle Cell Disease in the Emergency Department.

Lovett PB, Sule HP, Lopez BL.

Hematol Oncol Clin North Am. 2017 Dec;31(6):1061-1079. doi: 10.1016/j.hoc.2017.08.009. Review.

PMID:
29078924
4.

Sickle cell disease pain management in adolescents: a literature review.

Wilson BH, Nelson J.

Pain Manag Nurs. 2015 Apr;16(2):146-51. doi: 10.1016/j.pmn.2014.05.015. Epub 2014 Aug 28. Review.

PMID:
25175555
5.

Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.

Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L.

Pain. 2003 Mar;102(1-2):187-93.

PMID:
12620610
6.

Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.

De Franceschi L, Mura P, Schweiger V, Vencato E, Quaglia FM, Delmonte L, Evangelista M, Polati E, Olivieri O, Finco G.

Pain Pract. 2016 Jul;16(6):680-7. doi: 10.1111/papr.12313. Epub 2015 May 26.

PMID:
26009799
7.

Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.

Nottage KA, Hankins JS, Faughnan LG, James DM, Richardson J, Christensen R, Kang G, Smeltzer M, Cancio MI, Wang WC, Anghelescu DL.

Clin Trials. 2016 Aug;13(4):409-16. doi: 10.1177/1740774516636573. Epub 2016 Mar 21.

PMID:
27000103
8.

Pain in children and adolescents with sickle cell disease: a descriptive study.

Walco GA, Dampier CD.

J Pediatr Psychol. 1990 Oct;15(5):643-58.

PMID:
2283573
9.

Evidence-based management of sickle cell disease in the emergency department.

Glassberg J.

Emerg Med Pract. 2011 Aug;13(8):1-20; quiz 20. Review.

PMID:
22164362
10.

Sickle cell disease in the emergency department.

Lovett PB, Sule HP, Lopez BL.

Emerg Med Clin North Am. 2014 Aug;32(3):629-47. doi: 10.1016/j.emc.2014.04.011. Epub 2014 Jun 7. Review.

PMID:
25060254
11.

AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain.

Dampier C, Palermo TM, Darbari DS, Hassell K, Smith W, Zempsky W.

J Pain. 2017 May;18(5):490-498. doi: 10.1016/j.jpain.2016.12.016. Epub 2017 Jan 5.

12.

State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Puri L, Nottage KA, Hankins JS, Anghelescu DL.

Paediatr Drugs. 2018 Feb;20(1):29-42. doi: 10.1007/s40272-017-0263-z. Review.

PMID:
28853040
13.

Targeting novel mechanisms of pain in sickle cell disease.

Tran H, Gupta M, Gupta K.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):546-555. doi: 10.1182/asheducation-2017.1.546. Review.

14.

Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.

Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A.

Pediatr Blood Cancer. 2014 Apr;61(4):693-6. doi: 10.1002/pbc.24864. Epub 2013 Nov 19.

PMID:
24249617
15.

Barriers to effective pain management in sickle cell disease.

Wright K, Adeosum O.

Br J Nurs. 2009 Feb 12-25;18(3):158-61. Review.

PMID:
19223799
16.

A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial.

Williams H, Silva S, Simmons LA, Tanabe P.

Trials. 2017 May 15;18(1):218. doi: 10.1186/s13063-017-1948-x.

17.

IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Dampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, Weiner DL, Minniti CP, Krishnamurti L, Ataga KI, Eckman JR, Hsu LL, McClish D, McKinlay SM, Molokie R, Osunkwo I, Smith-Whitley K, Telen MJ; Sickle Cell Disease Clinical Research Network (SCDCRN).

Clin Trials. 2013 Apr;10(2):319-31. doi: 10.1177/1740774513475850.

18.

Novel Metrics in the Longitudinal Evaluation of Pain Data in Sickle Cell Disease.

Bakshi N, Smith ME, Ross D, Krishnamurti L.

Clin J Pain. 2017 Jun;33(6):517-527. doi: 10.1097/AJP.0000000000000431.

PMID:
27584817
19.

Improving Emergency Department-Based Care of Sickle Cell Pain.

Glassberg JA.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):412-417. doi: 10.1182/asheducation-2017.1.412. Review.

20.

Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.

Inoue S, Khan I, Mushtaq R, Sanikommu SR, Mbeumo C, LaChance J, Roebuck M.

Ann Hematol. 2016 Jan;95(2):221-5. doi: 10.1007/s00277-015-2558-x. Epub 2015 Nov 27.

PMID:
26611852

Supplemental Content

Support Center